M COTRINA
Overview
Explore the profile of M COTRINA including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buti M, Costa X, Valdes A, COTRINA M, Rodriguez Frias F, Jardi R, et al.
Gastroenterol Hepatol
. 2002 May;
25(5):295-8.
PMID: 11985798
Aim: To study hepatitis B virus (HBV) replication in a series of patients with HBV infection and to analyze the frequency of associated hepatitis C virus (HCV) and hepatitis D...
2.
Jardi R, Rodriguez F, Buti M, Costa X, COTRINA M, Valdes A, et al.
J Viral Hepat
. 2001 Nov;
8(6):465-71.
PMID: 11703579
A sensitive and accurate HBV DNA quantification assay is essential for monitoring hepatitis B virus (HBV) replication. This study evaluated a real-time PCR method performed in the LightCycler analyser for...
3.
Jardi R, Rodriguez F, Buti M, Costa X, COTRINA M, Galimany R, et al.
Hepatology
. 2001 Aug;
34(2):404-10.
PMID: 11481626
The interactions among hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) were studied by measuring HBV-DNA and HCV-RNA levels and by determining the influence of...
4.
Buti M, COTRINA M, Jardi R, de Castro E, Rodriguez-Frias F, Sanchez-Avila F, et al.
J Viral Hepat
. 2001 Jul;
8(4):270-5.
PMID: 11454178
There is no standard therapy for patients with anti-HBe-positive chronic hepatitis B. The aims of this study were to analyse the efficacy of lamivudine therapy for two years in these...
5.
Buti M, Sanchez F, COTRINA M, Jardi R, Rodriguez F, Esteban R, et al.
J Infect Dis
. 2001 Mar;
183(8):1277-80.
PMID: 11262212
To determine whether a dramatic decrease in hepatitis B virus (HBV) DNA levels within the first months of lamivudine therapy can predict the emergence of YMDD variants in patients with...
6.
Buti M, Jardi R, Bosch A, Rodriguez F, Sanchez G, Pinto R, et al.
Gastroenterol Hepatol
. 2001 Feb;
24(1):1-4.
PMID: 11219133
Assessment of viremia in hepatitis A virus (HAV) infection is not frequently performed with conventional methods because the techniques used are laborious, have low sensitivity are usually performed in feces....
7.
Pina S, Buti M, COTRINA M, Piella J, Girones R
J Hepatol
. 2000 Nov;
33(5):826-33.
PMID: 11097493
Background/aims: Hepatitis E virus (HEV) is an enterically transmitted pathogen that appears sporadically in non-endemic countries. We studied HEV as a causal agent of acute hepatitis cases in the Spanish...
8.
Olive G, Buti M, Ignacio Esteban J, COTRINA M, Esteban R, Guardia J
Med Clin (Barc)
. 2000 Oct;
115(7):254-5.
PMID: 11013148
Background: Patients with chronic hepatitis are in risk to acquire a fulminant hepatitis associated with hepatitis A virus superinfection. Patients And Methods: Antibodies against hepatitis A were study in serum...
9.
Rodriguez-Frias F, Gonzalez C, Costa X, Campos F, COTRINA M, Jardi R, et al.
Thorax
. 2000 Jul;
55(6):535-6.
PMID: 10896612
No abstract available.
10.
Costa X, Jardi R, Rodriguez F, Miravitlles M, COTRINA M, Gonzalez C, et al.
Eur Respir J
. 2000 Jul;
15(6):1111-5.
PMID: 10885432
The use of dried blood spot (DBS) specimens in quantitative alpha1-antitrypsin (alpha1-AT) detection or genetic analysis is limited because protein levels in the samples are low and they contain components...